TrialJAMA dermatology2020

Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial.

Claire Mignard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.